BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 9581729)

  • 21. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.
    Metra M; Eichhorn E; Abraham WT; Linseman J; Böhm M; Corbalan R; DeMets D; De Marco T; Elkayam U; Gerber M; Komajda M; Liu P; Mareev V; Perrone SV; Poole-Wilson P; Roecker E; Stewart J; Swedberg K; Tendera M; Wiens B; Bristow MR;
    Eur Heart J; 2009 Dec; 30(24):3015-26. PubMed ID: 19700774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inotropes and beta-blockers: is there a need for new guidelines?
    Bristow MR; Shakar SF; Linseman JV; Lowes BD
    J Card Fail; 2001 Jun; 7(2 Suppl 1):8-12. PubMed ID: 11605160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
    Groenning BA; Nilsson JC; Sondergaard L; Fritz-Hansen T; Larsson HB; Hildebrandt PR
    J Am Coll Cardiol; 2000 Dec; 36(7):2072-80. PubMed ID: 11127443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
    Ghio S; Constantin C; Raineri C; Fontana A; Klersy C; Campana C; Tavazzi L
    Cardiovasc Ultrasound; 2003 Sep; 1():13. PubMed ID: 14596683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.
    Sanderson JE; Chan SK; Yu CM; Yeung LY; Chan WM; Raymond K; Chan KW; Woo KS
    Heart; 1998 Jan; 79(1):86-92. PubMed ID: 9505927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure.
    Kukin ML; Kalman J; Mannino M; Freudenberger R; Buchholz C; Ocampo O
    Am J Cardiol; 1996 Mar; 77(7):486-91. PubMed ID: 8629589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
    Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
    Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.
    Narahara KA
    Am Heart J; 1991 May; 121(5):1471-9. PubMed ID: 1826806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
    Simonton CA; Daly PA; Kereiakes D; Modin G; Chatterjee K
    Chest; 1987 Jul; 92(1):118-23. PubMed ID: 2954776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Levine TB; Levine AB; Keteyian SJ; Narins B
    Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
    Ghali JK; Piña IL; Gottlieb SS; Deedwania PC; Wikstrand JC;
    Circulation; 2002 Apr; 105(13):1585-91. PubMed ID: 11927527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case studies in heart failure.
    Paul S; Trupp RJ
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):519-23, x. PubMed ID: 14717398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous milrinone in treatment of advanced congestive heart failure.
    Zewail AM; Nawar M; Vrtovec B; Eastwood C; Kar MN; Delgado RM
    Tex Heart Inst J; 2003; 30(2):109-13. PubMed ID: 12809251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
    Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of enoximone to adrenergic agents in the management of severe heart failure.
    Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
    Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.